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Abstract 
Biomaterial surface design with biomimetic proteins holds great promise for successful regeneration 
of tissues including bone. Here we report a novel proteinaceous hybrid matrix mimicking bone 
extracellular matrix that has multifunctional capacity to promote stem cell adhesion and osteogenesis 
with excellent stability. Osteocalcin-fibronectin fusion protein holding collagen binding domain was 
networked with fibrillar collagen, featuring bone extracellular matrix mimic, to provide multifunctional 
and structurally-stable biomatrices. The hybrid protein, integrated homogeneously with Col fibrillar 
networks, preserved structural stability over a month. Biological efficacy of the hybrid matrix was 
proven onto tethered surface of biopolymer porous scaffolds. Mesenchymal stem cells quickly 
anchored to the hybrid matrix, forming focal adhesions, and substantially conformed to cytoskeletal 
extensions, benefited from the fibronectin adhesive domains. Cells achieved high proliferative 
capacity to reach confluence rapidly and switched to a mature and osteogenic phenotype more 
effectively, resulting in greater osteogenic matrix syntheses and mineralization, driven by the 
engineered osteocalcin. The hybrid biomimetic matrix significantly improved in vivo bone formation in 
calvarial defects over 6 weeks. Based on the series of stimulated biological responses in vitro and in 
vivo the novel hybrid proteinaceous composition will be potentially useful as stem cell interfacing 
matrices for osteogenesis and bone regeneration.  
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1. Introduction 
 
Scaffolds with a capacity to repair and regenerate tissues including bone have undergone significant 
developments over the last few decades. In bone tissue engineering, scaffolds must satisfy a number 
of criteria including bioactivity, compatible surfaces for the control of cell fate, degradability within an 
appropriate time frame for substitution by neo-tissue, and three dimensional (3D) structures for 
inducing osteogenesis and angiogenesis [1].  
The surface of scaffolds is considered of particular importance to optimize the biological 
processes including initial cellular recognition, tissue specific commitment and subsequent repair and 
regeneration. Mimicking the interface to the tissue of concern is by far the most promising strategy to 
appropriately regulate cellular and tissue reactions to ensure the success of scaffolds clinically. In fact, 
the extracellular matrix (ECM) of the tissue provides the best micro-environmental conditions for the 
cells that are hosted and reside within it, and contain the necessary components required for tissue 
maintenance and recovery in the event of damage and disease [2].  
Bone is a highly organized tissue that comprises the major part of human hard tissues, and 
performs both mechanical and biological functions. Bone ECM consists of collagen (Col) and also 
non-collagenous proteins such as fibronectin (FN), osteocalcin (OC), osteopontin (OPN), and bone 
sialoprotein (BSP) [3,4]. As the most abundant ECM component, Col is involved primarily in providing 
mechanical strength and aiding in the formation of mineralized bone matrix. Therefore, Col has been 
widely used in various clinical and tissue engineering applications. The use of Col as an interface of 
biomaterials has been researched, with results demonstrating that Col-surfaces enhance the 
attachment, proliferation, and differentiation of osteoblastic/progenitor cells in vitro, and subsequent 
bone formation in vivo [5-8].  
Aside from the structural proteins, adhesive proteins such as fibronectin (FN), vitronectin, 
and laminin mediate cellular recognition of the underlying matrix through integrin signaling. FN is 
known to be a potent and dominant adhesive protein. FN contains three types of modules: I, II, and III, 
[9] and with respect to cell adhesion, the ninth and tenth domain of FN module III (FNIII9-10) contains 
Arg-Gly-Asp (RGD) and the synergic sequence Pro-His-Ser-Arg-Asn (PHSRN) is recognized to 
enhance cell adhesion, proliferation and differentiation of osteoblasts and progenitor cells [10,11]. 
However, the efficiency of the adhesive protein alone is not sufficient to stimulate differentiation and 
maturation (mineralization) of progenitor / stem cells in bone regenerative processes. In other words, 
some ECM proteins are critically involved in the differentiation and late stage mineralization of bone. 
Among else, OC is highlighted in this study. OC, the most abundant nanocollageneous protein in 
bone [4], accelerates mineral formation and growth due to its high affinity to the mineral crystals. In 
fact, OC has been recognized to be the key marker for late stage osteogenesis of progenitor / stem 
cells [12,13].  
We have recently synthesized a unique fusion protein, comprising OC and FNIII9-10 (OC-FN), 
which was aimed at regulating sequential functions of mesenchymal stem cells both in the initial 
adhesion and late osteogenesis processes [13,14]. Based on this, here we design bone ECM mimic 
matrix where Col was introduced as the structural support and network of the OC-FN. In particular, we 
engineered OC-FN with collagen binding domain (CBD) to form a structurally hybridized ECM network 
with better physicochemical stability. Some engineered proteins containing CBD have already shown 
good performance with Col materials [15,16]. Moreover, we induced sufficient fibrillogenesis of Col, 
which is known to be a key elemental process to preserve Col stability and its native functions. The 
monomeric Col in solution form does not resemble the naturally occurring functional fibrillar form of 
collagen (fCol). The Col coating with poor fibrillar formation led to a lack of appropriate cellular 
responses, such as cell attachment and proliferation of osteoblasts [6,17].  
Collectively, the proteinaceous matrix constituted of Col-OC-FN is considered to resemble 
the native bone ECM and to favor stem cell functions including initial adhesion and late osteogenic 
differentiation while preserving the structural stability. In particular, here we coupled the protein matrix 
to a 3D porous scaffold made of an easily manufacturable and clinically approved synthetic 
biopolymer, polycaprolactone (PCL). The scaffold is widely used due to appropriate biodegradation 
rate and mechanical strength, but the lack of cell recognition site and tissue specific activity has been 
indicated as a major limitation for bone regenerative scaffolds [18,19]. Therefore, this approach of 
tailoring the biopolymer scaffold surface constructs with a bone supportive ECM matrix is a facile 
promising approach for development of next generation bone scaffolds. The processes to generate 
the protein hybridized scaffolds are described and their biological impacts are demonstrated in terms 
of mesenchymal stem cell responses in vitro and bone formation in vivo.   
 
 
2. Materials and methods 
 
2.1. Construction and purification of recombinant fusion protein, (CBD)OC-FN 
To construct the (CBD)OC-FN, OC-FN DNA was initially amplified by the CBD-OC-Sac forward primer, 
5′-GGCGAGCTCACCAAAAAAACCCTGCGTACCCTCGAGTACC TGTATCAATGGCTG-3, the 
pBAD-His reverse primer, 5′-ACGGCGTTTCACTTCTGAG T -3’. PCR was conducted for 30 cycles of 
1 min at 55 °C (annealing), 2 min at 72 °C (extension), and 1 min at 94 °C (denaturation). Amplified 
PCR products were digested with SacI and HindIIII. After ligation into pBAD-HisA-OC-FNIII9-10 vector, 
pBAD-HisA-CBD-OC-FNIII9-10 constructs were produced. TOP10 E. coli, selected clones were grown 
in LB medium containing ampicillin overnight at 37 °C after transformation. When the absorbance of 
cultures reached 0.6 (A600), induction was initiated with L-arabinose (0.02% w/v) and incubated at 
20 °C for 6 h. The bacterial pellets were harvested by centrifugation at 6,000 x g for 10 min, lysed, 
and sonicated. A soluble extract obtained were centrifuged for 30 min at 14,000 x g in a refrigerated 
centrifuge and the supernatant was purified by affinity to a nickel-nitrilotriaceticacid resin (Invitrogen). 
To determine the protein, western blots were performed using a peroxidase conjugate of a 
monoclonal anti-polyhistidine antibody (SC-8036 HRP, SantaCruz). The degree of purification of the 
fusion protein was measured by carrying out sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) (Mw= 47 kDa) using SDS-PAGE at 10% (v/v). 
 
2.2. Fibrillar formation of proteins and surface tailoring of scaffolds 
The collagen type I solution (60-30-810, First link Ltd.) was diluted in PBS and allowed for fibrillar 
formation upon immersion in incubator at elevated temperatures. To prepare Col-(CBD)OC-FN 
solutions, the (CBD)OC-FN fusion protein was added to the Col solution in PBS at different 
concentrations (fusion protrein:Col = 1:100, 1:200, and 1:1000) before fibrillar formation. The degree 
of fibrillar formation of the protein solutions was characterized via turbidity test. The turbidity was 
monitored at 313 nm with varying incubation time, temperature and protein concentrations.  
As the framework of scaffolds, macrochanneled PCL were fabricated using a RD (Ez-
ROBO3, Iwashita) as described previously [20. Scaffold was designed and controlled by CAD 
program. Prior to fabrication of the 3D scaffolds, PCL (MW 80,000, Sigma-Aldrich) were dissolved in 
acetone and then ball milled at 50 °C. The temperature of the slurry was maintained via a thermo-
jacket during the fabrication. The struts were formed in an ethanol bath for the solidification of the 
slurry via the needle (0.33 mm). The scaffolds were designed as size of 9 x 9 mm and with 6 layers.  
For surface of PCL scaffolds was then tailored with the protein solutions. For this, the PCL 
scaffolds were first hydrolyzed and activated with a cross-linker (EDC-NHS). The pretreated scaffold 
was then immersed into the different protein solutions for predetermined time period at room 
temperature. The protein adherence to the surface was assessed by the detection of Col using Sirius 
Red staining method. Direct red 80 (365548, Sigma) dissolved in saturated picric acid was added to 
the scaffolds and then left for 1 h at room temperature. The stained samples were washed completely 
with 0.01 N HCl. The surface-adhered Col was quantified by elution with 200 µl of 0.5 M NaOH. The 
eluted solution was transferred to 96-well plates, and the optical density was measured at 540 nm. 
The values were converted to a Col concentration when referenced to a standard curve of Col 
solution [6]. The optical density (OD) by Sirius red assay showed a linear relationship with Col 
concentration; OD = 1.643 x Col concentration + 0.0269 (R2 = 0.99).  
The (CBD)OC-FN distribution within Col matrix was examined by TEM after dropping the 
protein solution on a Cu-grit, followed by staining with Au nanoparticles (ab154873, abcam) 
conjugated with OC-antibody. The (CBD)OC-FN within the Col-bound scaffolds was also directly 
visualized by immunostaining against OC. The scaffolds tailored with the proteins were put into OC 
antibody (1:200, SC-365797, Santacruz). After treatment with a blocking buffer to block nonspecific 
binding (5% skim milk), anti-mouse-Alexa Fluor 555 (1:500, A21422, Invitrogen) was used for 
conjugation with primary antibody. The fluorescence image was obtained by confocal laser scanning 
microscopy (CLSM, Carl Zeiss 510L, Germany). The intensity from the fluorescence image, 
corresponding to the quantity of fusion protein in the hybrid protein network, was measured using 
image J program (NIH).  
An indirect ELISA protocol was also used for the quantification of the fusion protein. After the 
adhesion, the non-bound protein solution was transferred into the 96 well of ELISA plates and 
incubated overnight at 4 °C. After blocking, the His-probe antibody (1:500, SC-8036, Santacruz) and 
secondary antibody (1:500, SC-2005, Santacruz) were bound with the His-tagged protein. As the 
substrate, 1-Step Turbo TMB-ELISA solution (34022, ThermoScientific) was used. After color change, 
the reaction was stopped using 2 N sulfuric acid. The absorbance was read at 450 nm using a 
microplate reader (SpectraMax M2e, Molecular Devices).The optical density was calibrated using 
protein standard curve. All values were normalized to the value for collagen. 
The surface-adhered morphology of the protein-tailored scaffolds was observed by scanning 
electron microscopy (SEM; JSM-6510, JEOL, Japan) and high resolution SEM (HR-SEM; MIRAII 
LMH, TESCAN, Czech Republic). The nanotopography of the proteins tethered on the scaffolds was 
examined by molecular force probe (MFP-3D-Bio, AsylumResearch, California, USA). To test wetting 
ability, samples were prepared by aligning strains in direct contacts by the RD machine. The water 
contact angle was measured using the sessile drop method. The pH of the Col solution was assessed 
to determine the effect of fibril formation using a pH meter (Thermo Scientific Orion 3 star, Cole-
Parmer, USA). 
 
2.3. Rat mesenchymal stem cells (rMSCs) and the adhesion and proliferation assays 
The rat MSCs were collected as detailed previously [21]. In brief, the bone marrow was harvested 
from femora and tibiae of adult rats (age 4 weeks, Korean) and was treated with collagenase type I. 
The suspension was sieved and centrifuged, and then the collected cells were cultured in total culture 
medium that is α-MEM supplemented with 10% fetal bovine serum and 1% penicillin/streptomycinin 
humidified atmosphere of 95% air and 5% CO2 at 37 °C. Non-adherent cells were removed by 
medium exchange and the cells were maintained to reach near confluence forming a monolayer and 
the passage 3 was used for further evaluations.  
Prior to seeding cells, the scaffolds were sterilized using 70% ethanol and UV light. The 
scaffold was put in the well plate and 1 x 105 cells in 100 µl culture medium were seeded on the 
scaffolds. After 1 h, the samples were transferred to 48 well plate and 800 µl fresh medium was then 
added into well. The medium was changed every other day.  
The cell adhesion and viability were determined by MTS assay, which is based on reduction 
of tetrazolium salt by dehydrogenases of mitochondria in cell to produce purple formazan crystals. 
The cultured cells on the scaffold were washed with PBS and transfer to new culture plate then 
incubated with 400 µl MTS solution, which was mixed as ratio of 10%CellTiter 96 AQueous One 
Solution (Promega) in medium, for 3 h at 37 °C. The 200 µl reactant was transferred into 96 well 
plates and the absorbance was measured at 590 nm.  
To observe the shape and morphology of rMSCs adhered onto the scaffolds, 
immunocytochemistry was carried out. After samples were fixed with 4% paraformaldehyde, the cells 
were permeabilized with 0.2% TritonX100. Anti-vinculin antibody (1:200 dilution, ab18058, abcam) 
was used as primary antibody. As the secondary antibody, fluorescein isothiocynate (FITC)-labeled 
antibody (sc-2010, SantaCruz) was used with phalloidin (A22283, Invitrogen) to stain F-actin and the 
nuclei were stained with DAPI (P36935, Invitrogen). Fluorescence images were taken by CLSM using 
z-stack mode. To analyze the size of cells spreading on the scaffolds, Zen 2009 image program was 
used.  
The expression of genes involved in the initial adhesion of the rMSCs was observed using 
reverse transcription polymerase chain reaction (RT-PCR). At predetermined time points, the cultured 
cells were harvested and RNA extraction was followed using the QiagenRNeasy mini kit instruction 
(Qiagen). The isolated RNA quantified was then converted to complementary DNA (cDNA) with first 
strand cDNA synthesis kit (PrimeScript RT reagent Kit, Bioneer, Korea). As the initial adhesion 
marker, the adhesive protein paxillin was detected. The primer was designed according to published 
cDNA sequences in GenBank. Glyceraldehyde phosphate dehydrogenase (GAPDH) was used as the 
housekeeping gene.  
To observe the morphology of cells on the scaffolds, the samples were fixed and 
permeabilized. For fluorescence image, the rMSCs on the scaffold were stained with phalloidin and 
DAPI. For SEM image, the samples were dehydrated with a gradient series of ethanol, treated with 
hexamethyldisilazane, and then coated with platinum.  
 
2.4. Osteogenic differentiation of MSCs and mineralization 
To confirm the osteogenic ability of the rMSCs grown on the protein-tailored scaffolds, the osteogenic 
medium, which is total culturing medium plus 50 µg/ml ascorbic acid, 10 mM β-glycerol phosphate, 
and 10 nM dexamethasone, was added and the cells were incubated for periods of up to 28 days. 
Alkaline phosphatase (ALP) activity, as an early marker of osteoblastic differentiation, was 
first determined. After the cells were lysed with RIPA buffer, the lysate solutions were reacted at 37 °C 
for 3 h with a reagent, composed of a mixture of 20 mM p-nitro phenol phosphate, 1.5 M 2-amino-
2methyl-1-propanol, and 1.0 mM MgCl2 at 1:1:1 ratio. After incubation, the samples were set on ice 
and the reaction stopped with 100 µl 1 M NaOH. The absorbance was measured at 405 nm and the 
amount of ALP was calculated as the p-nitrophenol standard curve. Finally, ALP activity was 
expressed as the value per unit double strand DNA (dsDNA) concentration which was measured 
using a Picogreen kit (Invitrogen).  
Cellular mineralization, a final stage of osteogenesis, was evaluated by Alizarin red S (ARS) 
staining method. The ARS dye was dissolved in distilled water and the pH was adjusted to 4.2 - 4.4 
using 10% (v/v) ammonium hydroxide. The ARS solution was added into each sample and left for 5 
min to react with calcium, after which the sample was washed completely with distilled water and 
then dried. To extract of the stained calcium, 10% cetylpyridinium chloride (CPC) was prepared and 
400 µl CPC was added in each sample. The value was expressed by the optical density (OD) at 405 
nm. The mineral elements (Ca and P) were detected by energy dispersive spectroscopy (EDS, 
Oxford), in conjunction with SEM. 
 
2.5. In vivo implantation in rat calvarium defect 
Ten weeks old male Sprague-Dawley rats (DaehanBiolink Co., Ltd, Chungbuk, Korea) were used in 
the in vivo experiments. Animals were maintained in a 12 h light/dark cycle (lights on from 8:00 to 
20:00), with relative humidity (30-70%) and temperature (20-24 °C)-controlled environment. The rats 
were allowed normal diet and water ad libitum. The experimental protocol for all animal care and use 
in this study was reviewed and approved in accordance with guidelines established by the Animal 
Care and Use Committee, Dankook University, Cheonan, Korea.  
General anesthesia was induced by an intramuscular injection a mixture of ketamine (80 
mg/kg) and xylazine (10 mg/kg). The animals were maintained under general anesthesia during the 
entire surgical procedure. The scaffolds with diameter of 5 mm were prepared sterile prior to use. The 
hair over the skin on the dorsal region of the cranium was shaved and the region was aseptically 
prepared using povidone and 70% ethanol for surgery. A linear sagittal midline skin incision was 
made over the calvarium with a #10 surgical blade. Full thickness flap of the skin and periosteum was 
elevated to obtain sufficient surgical field for the drilling. Two 5 mm diameter critically sized circular 
full-thickness calvarial bone defect were created in each rat, at the centre of each parietal bone. To 
create the defects without overheating of the bone edges, a trephine bur was used under constant 
irrigation with sterile saline solution, without damaging the underlying sagittal sinus and dura matter. 
The defects were randomly allocated into five groups; protein-free scaffold (PCL), protein 
tailored scaffolds with different (CBD)OC-FN fusion protein content of 0 (Col), 1 µg (1OCFN), 10 µg 
(10OCFN), and 100 µg (100OCFN). Total 15 animals (2 defects per animal) were used where six 
samples for each group were distributed into the defects. After the implantation, subcutaneous tissue 
was closed with absorbable materials (4-0 Vicryl, Ethicon, Norderstedt, Germany), and skin incisions 
were sutured with non-absorbable materials (4-0Dafilon, B. Braun Melsungen AG, Melsungen, 
Germany).  
The animals were housed individually in cages and monitored during the experimental time 
for signs of infection, inflammation, and any adverse reaction by visual observation. Six weeks 
following operation, the animals were sacrificed to collect the samples. Skin was dissected, and the 
tissues including the surgical sites and its surrounding tissues were harvested along with surrounding 
bone. The specimens were fixed in 10% buffered neutralized formalin for 24 h at room temperature 
and prepared for micro-CT (µCT) analysis and histology. 
 
2.6. Quantitative and qualitative assessments of bone formation 
Following fixation, the µCT images were performed to visualize the samples and measure defect 
closure for quantitative image analysis of new bone formation. The harvested specimens were 
scanned using µCT scanner (Skyscan 1176; Skyscan, Aartselaar, Belgium) with a camera pixel size 
of 12.56 µm, and a frame averaging of three was employed together with a filter of 1 mm aluminum, a 
rotation step of 0.5 °, the rotation angle was 180 °. The X-ray tube voltage was 65 kV and the current 
was 385 µA, with an exposure time of 279 ms. A cylindrical region of interest (ROI) was positioned 
over the center of the single defect, enclosed all the new bone within the defect site. Percent bone 
volume of newly formed bone within the ROI was measured and 3D µCT images were reconstructed 
through a computer analysis program, CTAn (Skyscan). The percentage of bone volume (%), bone 
surface (mm), and bone surface density (1/mm) of the newly formed bone within each ROI were 
measured by assigning a threshold for total bone content (including trabecular and cortical bone). 
After µCT imaging, the harvested samples were prepared for histological analysis. For this, 
fixed specimens were decalcified with RapidCalTM solution (BBC Chemical Co., Stanwood, WA, USA), 
dehydrated through a series of ethanol solutions of increasing concentration (from 70 to 100 %) and 
subsequently embedded in paraffin. Approximately 5 µm thick coronal sections were prepared at the 
central region of the circular defects using a microtome (RM2245, Leica, Germany) and defined as 
the representative histology. The slides were stained with hematoxylin & eosin (H&E) with routine 
techniques and examined using a light microscope (IX71, Olympus, Tokyo, Japan). Results of new 
bone formation within the defect were taken under 40 x magnification. 
 
2.7. Statistical analysis 
The data were presented as the mean and standard deviation (SD). The statistical difference between 
groups was carried out by analysis of variance (ANOVA), and the significance level was considered at 
p < 0.05. 
 
 
3. Results and discussion 
 
3.1. Protein mimics and engineering on scaffolds 
 
The schematic image of the currently used recombinant (CBD)OC-FN fusion protein is shown in Fig. 
1a, and Western blot analysis revealed a single protein band at around 50 kDa (Fig. 1b). The FN 
domain was structured to be tenth and ninth type III, which has a specific region of RGD and PHSRN 
respectively for cell adhesion. On the other hand, the OC, holding carboxyglutamate residues, has a 
high affinity for calcium ions thus potentially contributing to the later osteogenic differentiation and 
mineralization processes. Bi-functionality of the OC-FN fusion protein has already been shown with 
respect to initial cell adhesion and osteogenic differentiation [13,14,22]. The CBD linked to the OC-FN 
fusion protein has specific affinity to Col matrix, which is the major structural component of the current 
engineered ECM. The TKKTLRT short peptide sequence contained in CBD has previously been used 
to specifically bind to Col matrices [15,23]. We thus consider that the proteinaceous matrix of hybrid 
Col+(CBD)OC-FN, engineered as a surrogate bone ECM, will provide proper substrate conditions for 
cellular growth and osteogenesis.  
In particular, we paid attention to fibrillar formation of Col structure as this is the naturally 
occurring functional structure, which plays essential roles in triggering cellular responses and 
preserving structural integrity [6,17]. Generally, Col solutions are in acidic soluble form with 
monomeric tropocollagen state, necessitating optimal fibrillar formation. The degree of fibrillar 
formation was thus assessed by the change in turbidity of the solutions with time, set in different 
conditions such as variation in temperature (25 and 37 °C) and Col concentration in PBS (5, 10 and 
20%) [24-26]. Turbidity generally increased with time after some lag period, and then appeared to 
saturate within approximately 10 h (Fig. 1c). In the test at 25 °C with varying Col concentration, the 
turbidity increase was the most rapid and the OD value was the highest at 10% Col (10% > 5% > 
20%), although all concentrations profiled similar turbidity kinetics. With 10% Col, the temperature 
was again varied to 37 °C, where the turbidity increase was abrupt as early as within few minutes and 
then saturated with the maximal level lower than that measured at 25 °C. In the same context, Wood 
et al. also reported similar results at both 25 and 37 °C [24]. In the Col assembly process, the lag 
phase is critical for the nucleation of monomers and subsequent fibrillar formation with sufficient size. 
Based on these results, the assembly of 10% Col in PBS at 25 °C was selected as the optical 
condition. We next tested fibrillar formation of the Col+(CBD)OC-FN hybrid protein in a similar way to 
pure Col while varying the fusion protein concentrations (OC-FN per 200 µg Col = 0.1, 1 and 2 µg). 
The turbidity change behaved similarly for all protein compositions with only slight decrease with 
increasing OC-FN concentration (Fig. 1d).  
 
The hybrid protein, Col+(CBD)OC-FN, was primarily used to tailor the surface of 3D porous 
scaffolds, aiming to control the biointerface between scaffold and cells. 3D macrochanneled PCL 
scaffolds designed by robotic dispensing were used as model polymeric supports to determine the 
effects of engineered hybrid protein matrix in vitro and in vivo. After surface activation of the polymeric 
scaffold, a solution-based protein tethering under gentle agitation gave uniform protein distribution 
throughout the scaffold’s 3D macroporous network (Fig. 2a including inset red-colored scaffold image 
stained by Sirius red). Protein matrix covered the surface almost completely. Well-developed fibrillar 
Col structure was revealed on high resolution SEM images (Fig. 2b,c). Furthermore, the molecular 
force probe image revealed 3D topology of the hybrid protein on the scaffold, containing 67 nm D-
periodic patterns, which is typical of well-assembled fibrillar Col (Fig. 2d). The surface roughness 
change with the protein tailoring was found to be insignificant by the molecular force probing (data not 
shown). The existence of OC-FN in the hybrid network was, however, not easily recognized in the 
optical and electron microscopy. To reveal the OC-FN, the hybrid protein (1OCFN) prepared directly 
on Cu-grit was immunostained with Au nanoparticles (40 nm size) against OC and then observed by 
TEM (Fig. 2e). A number of dark spots were well visualized, evenly distributed throughout the matrix, 
which are assigned to be OC-FN, and the average density of the dots was 50/mm2 with single dot 
occupying approximately 20 nm2. When we consider the concentration ratio of Col and OC-FN pooled 
in the hybrid network, such a density level was calculated to be reasonable. 
 
The hybrid protein structured on the PCL scaffolds was quantified by Sirius red staining. The 
quantity of Col on the scaffold was around 130 µg without regard to the existence of OC-FN, which 
corresponds to 65% of the Col used initially (200 µg) (Fig. 3a). Furthermore, the quantity of OC-FN 
present on the Col network was analyzed by immunostaining with OC primary / HRP-conjugated 
secondary antibodies (Fig. 3b). Interestingly, the OC-FN present on the tethered Col network (~800 
ng) was higher than that on the solution Col state (~500 ng) by 1.6 times difference. The Col+OC-FN 
protein matrix integrated on PCL scaffold surface was further analyzed the degradation stability. The 
Sirius red assay of the protein remaining on the surface enabled us to characterize degradation of Col 
with time measured for up to 28 days (Fig. 3c). Col degradation with time was obvious; ~30% for the 
1st week, up to 45% during 2 weeks and up to 60% during 4 weeks. While the Col showed on-going 
degradation with time, the degradation of OC-FN in the Col was monitored by the fluorescence 
images with time (Fig. 3d). Interestingly, the fluorescence intensity changed very little (based on both 
images and quantification), preserving the initial fluorescence level prior to degradation test. The OC-
FN is considered to tightly bind to Col network without a premature release from the structure, being 
distributed at an almost equal quantity with respect to Col, which presumably preserve the 
fluorescence signals in the Col matrix, which remained in large amounts on the scaffold covering the 
surface completely.  
 
3.2. Cell adhesion, spreading and proliferation  
The cellular responses to the Col+(CBD)OC-FN protein interfaced scaffolds were investigated using 
rMSCs. Prior to in-depth cell tests, the effect of (CBD)OC-FN concentration on cell adhesion was first 
screened on a tissue culture plastic during 4 h by means of MTS assay. Cell adhesion gradually 
increased with increasing protein concentration up to 1 µg, after which showing a plateau up to 10 µg. 
Based on this, we used the 1OCFN as the representative of hybrid protein matrix, and Col matrix and 
bare PCL for comparison groups. In Fig. 4a, the cellular adhesion was monitored at the varying time 
points (2, 4, and 8 h). While cell adhesion was largely limited on PCL, Col tailoring substantially 
increased the cell adhesion level. Furthermore, 1OCFN group improved the cell adhesion more 
significantly. This was particularly evident at the very initial period of cellular adhesion as early as 2 h, 
where a big difference in the adhesive level between the groups was seen. The mRNA expression of 
paxillin (PAX), a representative of adhesive proteins involved in the early cell adhesion processes, 
was also significantly stimulated by the engineered proteins at the early periods tested (1OCFN > Col 
> PCL) (Fig. 4b).  
 
The initial cell adhesion and spreading behaviors were visualized by CLSM after co-
immunostaining of nuclei with DAPI (blue), F-actins with phalloidin (red) as well as vinculin (green) 
(Fig. 5a). Only few cells were found on PCL, where the F-actins and vinculin stains were also in very 
limited area. On Col-surfaced scaffold, more cells were found and the cells extended better with a 
spreading morphology and with more intensified vinculin signals at the periphery, particularly at 4 h. 
On 1OCFN-tethered surface, the cellular extension was substantial as early as 2 h, with similar 
patterns to those noticed in Col matrix at 4 h. While the cell morphology was rather rounded at 2 h in 
1OCFN (vs. 4 h in case of Col), it became irregular with more lamellar extensions in certain directions, 
possibly due to the shift from filopodia to lamellipodia extensions [27,28]. Furthermore, whilst the 
vinculin signals were mostly obvious at the periphery at 2 h, the signals became diffused after 4 h, 
signifying possible change in spatial distribution of adhesion complex proteins, the phenomenon often 
known as when cells underwent substantial spreading from initial focal contacts. The cell spreading 
behavior was subsequently quantified to define cell spreading area and perimeter (Fig. 5b). 
Compared to pure PCL scaffolds, the protein-tailored scaffolds showed significantly higher values of 
both indices and the 1OCFN group showed the higher values. Furthermore, while there was little 
change with culture time in both indices in the PCL scaffold, there was substantial increase with time 
for both protein-surfaced scaffolds. At 4 h, the cell perimeters on Col and 1OCFN were 3.9- and 5.2-
fold higher, and the areas were 4.6- and 8.6-fold higher, than those on PCL. In comparing between 
Col and 1OCFN, the cell perimeter and area were 1.3- and 2.8-fold difference, respectively.  
Taking all the cellular adhesion studies, rMSCs were stimulated to better recognize the 
hybrid protein matrix, with significantly higher cellular anchorage, and then conformed to spread more 
quickly with expressions of focal adhesive molecules at the gene and protein levels and with apparent 
cytoskeleton extensions. While the Col, with its adhesive ligands, also substantially improved those 
adhesion behaviors of rMSCs to the cell-ligand free PCL surface, the involvement of FN with the III9-
10 adhesive domains invoked significant improvement of rMSCs adhesion behaviors. In fact, FN, 
among other adhesive proteins including Col, vitronectin and laminin, has shown the greatest 
potential for MSCs adhesion process through signaling of integrins such as ανβ3 and α5β1 [29].  
 
 After confirming the stimulatory effects on rMSCs adhesion and spreading, we next 
examined the cell proliferative behaviors on the protein matrices. The MTS optical density, 
corresponding to cell viability, was plotted at each culture period for up to 14 days (Fig. 6a). The 
difference in MTS level, noticed as early as day 1, was preserved up to the test period. The MTS 
increment with time was also plotted to examine the cell proliferative potential (Fig. 6b). In Col and 
1OCFN groups, the proliferative potential was relatively higher at initial periods (< 7 days), but 
decreased as the culture time increased. On the other hand, in the PCL group, the proliferative 
potential was low initially (< 7 days) and then became increased substantially after 7 days. It is thus 
considered that when the protein matrix was interfaced, the rMSCs acquired proliferative capacity 
more quickly to reach confluence and subsequently switched to next cellular processes involving 
prominently differentiation.12 The representative morphologies of cells grown on the 1OCFN-tailored 
scaffolds were observed using SEM and CLSM (Fig. 6c-e). At 14 days cells already reached 
confluence (Fig. 6c), covering the scaffold surface almost completely in a uniform way, as examined 
by a cross-sectioned SEM image (Fig. 6d), moreover, confocal image revealed a number of 
cytoskeletal processed networks and formation of thick cell-ECM constructs throughout the scaffolds, 
an indication that cells secreted a bunch of matrix molecules at this culture period (Fig. 6e).  
 
3.3. Osteogenic differentiation 
After confirming stimulation of rMSC responses including initial adhesion, spreading and time-
sequenced proliferation, we next examined the osteogenic differentiation of cells. Alkaline 
phosphatase (ALP), which is regarded as an early marker of osteogenesis, was substantially 
expressed during the culture from 7 to 14 days, with significantly higher levels on Col than on PCL as 
well as those on 1OCFN than on Col. The ALP level from 14 to 21 days was strongly reduced in both 
Col and 1OCFN, which however, was slightly increased in PCL (Fig. 7a). Because ALP is 
representative of early osteogenic marker, the rMSCs at the relatively prolonged culture over 14 days 
will reduce ALP activity and predominantly secret other ECMs that are required at much later stage of 
osteogenesis and mineralization, demonstrating the rMSCs grown on the protein-tailored scaffolds 
underwent substantial degree of osteogenic differentiation, expressing ALP earlier in culture.  
Lastly, the cellular mineralization was assessed at prolonged culture periods of up to 28 days 
by Alizarin red staining (ARS) (Fig. 7b). From the ARS optical images, the mineral deposit on the 
1OCFN-tailored scaffolds revealed much clearer red staining. From quantification of the stained 
extracts, the mineralization level substantially increased with culture period on both Col and 1OCFN-
tailored groups (even better on 1OCFN) than on PCL, which showed very limited change with time. 
As a consequence, significantly higher mineralization was recorded in the sequence: 1OCFN > Col > 
PCL. To confirm the atomic composition of the mineral deposits, we gathered the deposits and 
analyzed with EDS equipped with TEM (Fig. 7c). The EDS spectra of cellular deposits in 1OCFN 
group revealed high intensities of Ca and P peaks, with a Ca/P ratio of 1.507, a value similar to but 
lower than the stoichiometry of hydroxyapatite. The appearance of S might be cellular components or 
organic ECMs additionally present on the EDS sample. The mineralization data demonstrates well the 
potential of the OCFN in the finalizing stage of MSCs osteogenesis. In this mineralization phase, the 
presence of ECM plays critical roles in capturing and precipitating calcium and phosphate ions. Other 
than Col, which is exogenous and rich in the matrix, many endogenous ECM proteins that were 
secreted by the cells, such as OP and BSP as revealed in our study as well, should affect the cellular 
mineralization process. Among other ECM molecules, the OC, used as the key exogenous moiety in 
the hybrid matrix, has been a potent calcium binding protein, critically involved in accelerating cellular 
mineralization.29 Taken together the in vitro findings, the hybrid proteinaceous matrix of 
Col+(CBD)OC-FN stimulated rMSCs in the series of responses from the early adhesion phase to late 
osteogenesis and mineralization.  
 
3.6. In vivo bone formation 
The in vivo effects of the hybrid protein tailoring of the scaffolds on bone regeneration were assayed 
using a rat calvarial defect model (as shown the in vivo model in Fig. 8a). The in vitro experiments 
clearly showed the effectiveness of the (CBD)OC-FN concentration 1 µg. Therefore, we carried out 
the in vivo study with this sample group, which resulted in very marginal improvement in bone 
regeneration. We considered the dose needed in the in vivo condition might be higher than that in 
cellular studies in vitro. We thus redesigned the in vivo experiments with increasing protein 
concentrations at 10 and 100 µg. After implantation of scaffolds (PCL, Col, 1OCFN, 10OCFN, and 
100 OCFN) for 6 weeks, the degree of bone growth was assessed by using µCT. Fig. 8b shows the 
representative planar views of the µCT-constructed images of all groups. There was little bone 
formation within the defect region in the negative control, confirming the critical-sized defect of the 
model. Within the pure PCL scaffold, some level of new bone was formed, suggesting the 
osteoconductive role of porous scaffolds. When Col-surfaced scaffold was used, bone formation 
appeared to be increased. When the fusion protein OCFN was hybridized with Col, the scaffolds 
increased the bone formation, and particularly with 100OCFN almost all the defect was filled with 
newly formed bone on planar view. The 3D de novo bone structure was further analyzed by µCT 
software to characterize bone volume, bone surface and bone surface density (Fig. 8c). The bone 
volume was significantly increased with the Col-tailoring, and the involvement of OCFN in Col further 
increased in concentration-dependent manner; significant improvements were noticed with 10OCFN 
and 100OCFN, whilst not with 1OCFN. The bone surface and surface density were also significantly 
improved with 100OCFN with respect to Col, which however, was not recognized with 1OCFN and 
10OCFN. While the bone volume means the quantity of regenerated bone, the bone surface density 
reflects the quality of regenerated bone in the entire bone-defect region based on the information of 
bone volume and bone surface. It is thus clear that the in vivo effects of OCFN in Col matrix were 
more obvious, not only in the quantity but in the quality also, when the concentration was over 10 µg. 
This concentration range was much higher than the concentration (1 µg) effective in vitro on rMSCs 
responses. This is an important consideration because translating from simple in vitro models to 
physiologic systems places a more severe set of demands on a system and so dosage or drug 
concentration will need to be changed accordingly. The more dynamic and harsh in vivo conditions 
compared to confined and simple in vitro cell culture conditions might require higher doses of 
therapeutic molecules that are effective in recruiting progenitor / stem cells, anchoring them, 
stimulating them to secret matrix molecules, before subsequent mineralization. It should be 
underscored though that with the higher in vivo dose, the stimulatory role of OCFN+Col matrix in bone 
regeneration was noteworthy; compared with PCL or Col groups, the increase in bone volume was 
from 25-30% to 50-60% (2-fold) and that in bone surface density was from 4-4.5 mm-1 to 6-7 mm-1 
(1.5 fold).  
 
Histological analyses of the tissue samples were also carried out with H&E staining after 
decalcification. The histological images support well the µCT results. Complete bridging of the defect 
gap through bone regeneration was only observed in 100OCFN group while partial limited bone 
regenerations were noticed in other scaffolding groups, with no bone-like tissues in the blank control 
(Fig. 9a). A closer examination of the histological images gave the information on tissue responses 
and bone quality (Fig. 9b). The scaffold surface was in direct contact with the newly formed bone 
without interposition of connective tissues. The newly formed bone in the 100OCFN group was largely 
mature and compact with a lining of osteoblasts, confirming the lamellar-structured bone, and some 
areas were comprised of loosely organized woven bone matrix, which would possibly be replaced 
with lamellar bone by remodeling process with time. Moreover, bone marrows were only formed in the 
new bone matrix of the 100OCFN group. This histological feature of bone quality also demonstrates 
the effective potential of the engineered protein matrix to create rapid bone formation and its 
subsequent remodeling during the 6 weeks of implantation period to conform to matured lamella 
structure.  
 
4. Summarizing scheme 
In summarizing the present findings, we illustrate a scheme of the possible series of 
reactions involved in the stimulatory roles played by the mimetic hybrid Col+(CBD)OC-FN matrices 
(Fig. 10). MSCs specifically recognize the ligand, FN’s adhesive module III, domain 9-10 sequence 
through well-known integrin subset α5β1, quickly anchor to the matrix, form substantial focal 
adhesions and then conform to cytoskeletal extensions. The rapidly adherent and spreading cells 
obtain high proliferative capacity to reach relatively early confluence and switch to osteogenic 
differentiation when provided with proper biochemical cues, inducing down-regulation of genes 
associated with cell growth and up-regulation of genes involved in osteogenesis. While MSCs secrete 
several ECM molecules during multiplication and osteogenesis with time, the exogenous OC protein 
appropriately fused to Col fibrillar matrix essentially drives osteogenesis by stem cells, particularly the 
late stage mineralization process, by capturing / precipitating calcium ions present in culture medium 
or in vivo body fluid and subsequently acquiring phosphate group that enzymatically generated in the 
cells.  
This series of stimulatory reactions in vitro and in vivo, driven by an engineered bone ECM 
matrix, were well demonstrated when tailored to the surface of biopolymer PCL scaffold. The current 
novel biomimetic matrix and the tailored scaffold will thus be potentially and extensively applicable for 
the repair and regeneration of bone.  
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Figure Caption 
 
Figure 1. (a) Schematic representation of the 3D structure of functional fusion protein, (CBD)OC-FN, 
as illustrated using the Pymol program, and (b) Western blot showing protein expression band. (c) 
Turbidity curves of fibrillar collagen solution in PBS recorded with respect to incubation time at varying 
temperatures and Col concentrations, and (d) the turbidity curves with the incorporation of fusion 
protein at varying concentrations (10% Col and 25 oC).  
Figure 2. (a-c) SEM morphologies, showing the hybrid protein Col+(CBD)OC-FN tailored on PCL 
scaffolds at different magnifications. Sirius red S assay shows a uniform distribution of the fusion 
protein throughout the scaffold (inset in (a)). Fibrillar structure of the hybrid protein networks was 
clearly revealed (arrowed in (c)). (d) Molecular force probe representative images also revealed the 
fibrillar formed surface. (e) TEM image showing the fibrillar Col and fusion protein dotted with AuNP 
stains.  
Figure 3. (a,b) Quantification of the protein contents tethered on the scaffold surface; Col content with 
or without the fusion protein showing similar levels of an average of 120 mg per scaffold sample, as 
quantified by Sirius red assay (a), and the fusion protein quantity present within Col fibrillar structure 
either adhered to the scaffold surface (‘(+)scaffold’) or remained in the solution (‘(-)scaffold’) (b). (c,d) 
Stability of the hybrid protein on the scaffolds measured in PBS for up to 28 days; While Col remained 
on the scaffolds shows a gradual release (c), the fusion protein in the Col network preserved well the 
fluorescence intensity (including representative images in inset, detected against anti-OC) up to the 
test period (d).    
Figure 4. Initial adhesion behaviors of rMSCs, as assessed by the adhesion rate and gene 
expression. (a) Adhesion level of cells on the three different scaffolds at varying culture time points. 
Significantly higher cell adhesion noticed at all time points with fusion protein tailoring (n = 3). (b) 
Paxillin (PAX) mRNA expression of the rMSCs on the scaffolds by RT-PCR, at the earliest stage of 
cell adhesion (20 and 40 min). Band intensities from three replicate experiments compared when 
normalized to GAPDH, showing significant stimulation with fusion protein tailoring.  
Figure 5. Cell spreading behaviors examined. (a) CLSM images of cells at 2 and 4 h revealing nuclei 
in blue, F-actin in red and vinculin in green, and (b) the cell spreading area and periphery length of 
cells measured by Zen 2009 program (n = 20). (* p < 0.05, PCL vs. Col; # p < 0.05, Col vs. OCFN).  
Figure 6. rMSCs proliferation behaviors on the scaffolds during culture for up to 14 days. (a) Cell 
proliferation measured by MTS assay, and (b) proliferation rate (increase per day) during each time 
interval (n = 3). (c,d) Cell proliferative morphology at 14 days taken by SEM (plane view in (c) and 
cross-section view in (d)) and CLSM (e; nuclei in blue and F-actins in red).  
Figure 7. Osteogenic differentiation and mineralization behaviors of rMSCs on the protein-tailored 
scaffolds. (a) ALP activity of cells measured up to 21 days (n = 5). (b) Cellular mineralization up to 28 
daus, as quantified by ARS assay (n = 5). Red-stained images included. (c) EDS analysis of Ca and P 
elements deposited in the cellular matrix at 28 days.   
Figure 8. In vivo bone regeneration examined in rat calvarium model after 6 weeks of implantation of 
the scaffolds. Experimental groups include empty control (-), pure PCL, with Col, and with OCFN at 
varying concentrations; 1OCFN, 10OCFN, and 100OCFN). (A) Two 6-mm circular defects generated 
in rat calvarium and the scaffolds implanted. (b) Micro-CT 3D reconstructed images of different 
sample groups, and (c) the image analyses of the newly formed bone, revealing bone volume, bone 
surface, and bone surface density.  
Figure 9. Histological images taken at (a) low and (b) high magnifications. Enlarged images of 
100OCFN are shown representatively (H&E stains).  
Figure 10. Scheme illustrating possible series of reactions involved in the stimulatory roles played by 
the mimetic hybrid Col+(CBD)OC-FN matrices in MSCs. Cells specifically recognize the ligand, FN’s 
adhesive module III, domain 9-10 sequence through well-known integrin subsets ανβ3 and α5β1, 
quickly anchor to the matrix, form substantial focal adhesions and then conform to cytoskeletal 
extensions. Rapidly adherent and spreading cells obtain high proliferative capacity to reach relatively 
early confluence and switch to an osteogenic differentiation when provided with proper biochemical 
cues. While MSCs secrete several ECM molecules like BSP and OPN during multiplication and 
osteogenesis with time, the exogenous OC protein appropriately fused to Col fibrillar matrix 
essentially drives osteogenesis of stem cells, particularly the late stage mineralization process, by 
capturing / precipitating calcium ions present in culture medium or in vivo body fluid and subsequently 
acquiring phosphate group that enzymatically generated in the cells. 
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